Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Engineering Laboratory of Thyroid Disease Prevention and Control, Changchun, Jilin, China.
Division for Endocrine and Minimally Invasive Surgery, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital G. Martino, University of Messina, Via C. Valeria 1, 98125, Messina, Italy.
J Endocrinol Invest. 2020 Sep;43(9):1283-1299. doi: 10.1007/s40618-020-01216-6. Epub 2020 Mar 12.
This retrospective study aimed to assess the association between obesity, gender, and specific clinicopathological features in patients with papillary thyroid cancer (PTC) and whether diagnostic ultrasonography (US) is adversely affected by obesity in these patients.
This study retrospectively analyzed 13,995 adult patients with PTC from a single medical center in China. Data stratification was performed to assess the association of obesity with US features and aggressive clinicopathological features in different models according to the World Health Organization Body Mass Index (WHO-BMI) and Chinese BMI classification (CN-BMI). The odds ratio (OR) of malignant US features and aggressive clinicopathological features was calculated from binary logistic regression models.
The BMI, obesity ratio, malignant US features, and aggressive pathological characteristics of males were significantly higher than those of females. After adjusting for confounding factors, the association of obesity with malignant US features and aggressive pathological characteristics was found to be sex-dependent. Next, obesity (WHO-BMI) was found to have an "interfering effect" on the US assessment of PTC (OR = 0.754, 95% CI 0.609-0.932, P = 0.009) in women. Among both sexes, obesity (WHO-BMI) increased the risk of tumor size (OR = 1.539 and OR = 1.521) and multifocality (OR = 1.659 and OR = 1.449). However, obesity did not increase the risk of capsular invasion or tumor staging in males. The above results are consistent with the CN-BMI. In addition, age was found to have an "interfering effect" on the US evaluation of malignant nodules in both sexes.
The results of our study confirm that higher BMI is significantly associated with aggressive clinicopathological features of PTC. Gender differences were present with obesity ratios and aggressive clinicopathological features being significantly higher in men.
本回顾性研究旨在评估肥胖、性别与甲状腺乳头状癌(PTC)患者特定临床病理特征之间的关系,并探讨肥胖是否会对这些患者的诊断性超声(US)检查产生不利影响。
本研究对来自中国某单一医疗中心的 13995 例成人 PTC 患者进行了回顾性分析。根据世界卫生组织(WHO)身体质量指数(BMI)和中国 BMI 分类(CN-BMI),对数据进行分层,以评估肥胖与不同模型中 US 特征和侵袭性临床病理特征的相关性。采用二元逻辑回归模型计算恶性 US 特征和侵袭性临床病理特征的优势比(OR)。
男性的 BMI、肥胖率、恶性 US 特征和侵袭性病理特征均显著高于女性。在调整混杂因素后,发现肥胖与恶性 US 特征和侵袭性病理特征之间的关系存在性别依赖性。此外,肥胖(WHO-BMI)被发现对女性 PTC 的 US 评估具有“干扰效应”(OR=0.754,95%CI 0.609-0.932,P=0.009)。在男女两性中,肥胖(WHO-BMI)均增加了肿瘤大小(OR=1.539 和 OR=1.521)和多灶性(OR=1.659 和 OR=1.449)的风险。然而,肥胖并未增加男性的包膜侵犯或肿瘤分期风险。以上结果与 CN-BMI 一致。此外,年龄对两性恶性结节的 US 评估均具有“干扰效应”。
本研究结果证实,较高的 BMI 与 PTC 的侵袭性临床病理特征显著相关。性别差异存在,男性的肥胖率和侵袭性临床病理特征明显更高。